Please login to the form below

Not currently logged in
Email:
Password:

Therapy Area

This page shows the latest Therapy Area news and features for those working in and with pharma, biotech and healthcare.

Catalent preps for complex therapy boom with $1.2bn Paragon buy

Catalent preps for complex therapy boom with $1.2bn Paragon buy

vectors, and 50% of all its work is in the gene therapy area. ... The deal comes amid something of a gene therapy buying spree among big pharma companies trying to get a position in the market.

Latest news

  • Tecentriq combo shows promise in triple negative breast cancer Tecentriq combo shows promise in triple negative breast cancer

    While Roche has sprung into the lead in the therapy area, Merck &Co is expecting results of two TNBC studies to emerge soon. ... can get approval in this area.

  • AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

    Analysts say the drug could be a best-in-class candidate in the therapy area. ... Analysts have marked out the drug as a potential best-in-class in the therapy area thanks to strong results in a three-way head-to-head comparing it with Johnson

  • EU approval for Opdivo combo in renal cell cancer EU approval for Opdivo combo in renal cell cancer

    This follows US approval last year, and is the first Immuno-Oncology (IO) combination therapy for patients with this type of cancer in the European Union. ... These rival combinations have produced trial data suggesting they could also help a wider

  • Gradually, then suddenly Gradually, then suddenly

    I asked the group some simple questions – the growth rate of an important therapy area, the number of rivals’ products in the pipeline – and I received quick, unequivocal answers. ... The second kept on looking for whole-disease area blockbusters

  • EMA sees approval numbers rise in 2018 EMA sees approval numbers rise in 2018

    From these, 21 were orphan medicines (exactly 50%) and three were advanced therapy medicinal products – Novartis’ Kymriah and Gilead/Kite’s Yescarta CAR-T therapies, plus Spark’s Luxturna, co-marketed ... Unsurprisingly, cancer drugs were the

More from news
Approximately 0 fully matching, plus 208 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The therapy area is dominated by Merck’s Keytruda, BMS’ Opdivo and Roche’s Tecentriq, but Pfizer is hoping that combinations such as its own Inlyta and Bavencio can help it ... It has gene therapy deals with Spark in haemophilia and with Sangamo in

  • Trust me, I’m from pharma Trust me, I’m from pharma

    The pioneering companies are those who are not focused simply on selling their drugs – they are committed to a therapy area, committed to the experts and, fundamentally, committed to the patients.

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    But if you or your company is new to a therapy area, you may wish to use KOL profiling or mapping to help identify the right candidates.

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    Our mindset needs to change. In our planning meetings we need to discuss how we can change patients’ lives in a therapy area, what outcomes matter to patients, and how we

  • A marathon and a sprint A marathon and a sprint

    He responded that he currently has reps from five large pharmaceutical companies offering him the exact same ‘added-value’ service within the same therapy area. ... Although the congress had over 1, 000 delegates, the experience we created targeted

More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 75 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Fendix is the only NHS digital media network and it provides organisations, such as pharma, with unrivalled digital access to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics